IgM and IgG antibodies to human T cell lymphotropic retrovirus (HTLV-III) in lymphadenopathy syndrome and subjects at risk for AIDS in Italy

A study was performed to assess the prevalence of specific antibodies to human T cell lymphotropic retrovirus (HTLV-III) in patients with lymphadenopathy syndrome, patients with the acquired immune deficiency syndrome (AIDS), and those at risk of AIDS. Serum samples were obtained from these groups a...

Full description

Saved in:
Bibliographic Details
Published inBritish Medical Journal (Clinical research ed.) Vol. 291; no. 6489; pp. 165 - 166
Main Authors Aiuti, F, Rossi, P, Sirianni, M C, Carbonari, M, Popovic, M, Sarngadharan, M G, Contu, L, Moroni, M, Romagnani, S, Gallo, R C
Format Journal Article
LanguageEnglish
Published England British Medical Journal Publishing Group 20.07.1985
British Medical Association
BMJ Publishing Group LTD
Subjects
Online AccessGet full text
ISSN0267-0623
1468-5833
DOI10.1136/bmj.291.6489.165

Cover

Loading…
More Information
Summary:A study was performed to assess the prevalence of specific antibodies to human T cell lymphotropic retrovirus (HTLV-III) in patients with lymphadenopathy syndrome, patients with the acquired immune deficiency syndrome (AIDS), and those at risk of AIDS. Serum samples were obtained from these groups and from healthy controls in selected cities in Italy, and antibodies to HTLV-III were measured by immunofluorescence assay and, in a few patients, by Western blotting. In addition, IgM antibody values were measured in 82 of those positive for HTLV-III. Altogether, 235 out of 320 patients with lymphadenopathy syndrome had antibodies to HTLV-III, the proportions being highest in haemophiliacs, homosexuals, and drug addicts from Rome; 11 out of 12 patients with AIDS had antibodies; 78 out of 439 subjects at risk for AIDS had antibodies; and six out of 30 patients with lymphadenopathy syndrome and positive for HTLV-III antibodies and nine of 52 patients at risk of AIDS had a detectable titre of IgM. HTLV-III is widespread in groups at risk of AIDS in Italy, and antibodies to HTLV-III are highly prevalent in patients with lymphadenopathy syndrome. A higher proportion of drug abusers were positive for antibodies than in previous studies. HTLV-III "infection" would appear to be spread mainly in compromised hosts, as none of the controls were positive for antibodies.
Bibliography:PMID:2990634
istex:7C4318193C9F2160F5D133206D6248293909537C
ark:/67375/NVC-KTX4RDRN-R
local:bmj;291/6489/165
href:bmj-291-165.pdf
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0267-0623
1468-5833
DOI:10.1136/bmj.291.6489.165